SenesTech (SNES) Competitors $2.93 -0.08 (-2.66%) (As of 12/20/2024 05:31 PM ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends SNES vs. EVGN, GURE, NITO, CNEY, TANH, GAMCW, LNZAW, ORGNW, PCTTW, and PCTTUShould you be buying SenesTech stock or one of its competitors? The main competitors of SenesTech include Evogene (EVGN), Gulf Resources (GURE), N2OFF (NITO), CN Energy Group. (CNEY), Tantech (TANH), Golden Arrow Merger (GAMCW), LanzaTech Global (LNZAW), Origin Materials (ORGNW), PureCycle Technologies (PCTTW), and PureCycle Technologies (PCTTU). These companies are all part of the "chemicals" industry. SenesTech vs. Evogene Gulf Resources N2OFF CN Energy Group. Tantech Golden Arrow Merger LanzaTech Global Origin Materials PureCycle Technologies PureCycle Technologies SenesTech (NASDAQ:SNES) and Evogene (NASDAQ:EVGN) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, risk, dividends, community ranking, valuation, analyst recommendations, media sentiment, profitability and earnings. Does the media refer more to SNES or EVGN? In the previous week, SenesTech and SenesTech both had 2 articles in the media. SenesTech's average media sentiment score of 0.00 equaled Evogene'saverage media sentiment score. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment SenesTech 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Evogene 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Do analysts rate SNES or EVGN? SenesTech presently has a consensus price target of $10.00, indicating a potential upside of 241.30%. Evogene has a consensus price target of $12.00, indicating a potential upside of 788.89%. Given Evogene's higher possible upside, analysts clearly believe Evogene is more favorable than SenesTech.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score SenesTech 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00Evogene 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Which has stronger earnings & valuation, SNES or EVGN? SenesTech has higher earnings, but lower revenue than Evogene. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSenesTech$1.65M1.84-$7.71MN/AN/AEvogene$7.48M0.97-$23.88M-$4.47-0.30 Do institutionals and insiders believe in SNES or EVGN? 5.2% of SenesTech shares are held by institutional investors. Comparatively, 10.4% of Evogene shares are held by institutional investors. 10.0% of SenesTech shares are held by insiders. Comparatively, 7.4% of Evogene shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth. Is SNES or EVGN more profitable? Evogene has a net margin of -314.43% compared to SenesTech's net margin of -403.51%. Evogene's return on equity of -109.05% beat SenesTech's return on equity.Company Net Margins Return on Equity Return on Assets SenesTech-403.51% -150.33% -125.40% Evogene -314.43%-109.05%-52.55% Which has more risk & volatility, SNES or EVGN? SenesTech has a beta of 0.52, meaning that its stock price is 48% less volatile than the S&P 500. Comparatively, Evogene has a beta of 1.36, meaning that its stock price is 36% more volatile than the S&P 500. Does the MarketBeat Community believe in SNES or EVGN? SenesTech received 102 more outperform votes than Evogene when rated by MarketBeat users. Likewise, 61.69% of users gave SenesTech an outperform vote while only 55.56% of users gave Evogene an outperform vote. CompanyUnderperformOutperformSenesTechOutperform Votes32261.69% Underperform Votes20038.31% EvogeneOutperform Votes22055.56% Underperform Votes17644.44% SummaryEvogene beats SenesTech on 7 of the 12 factors compared between the two stocks. Ad Crypto Swap ProfitsURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happens like clockwork every 4 years, during the December to February window of a Bitcoin halving year. This is where fortunes are made – often LITERALLY overnight.>> Register for the Workshop Now Get SenesTech News Delivered to You Automatically Sign up to receive the latest news and ratings for SNES and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SNES vs. The Competition Export to ExcelMetricSenesTechAgricultural chemicals IndustryMedical SectorNASDAQ ExchangeMarket Cap$3.11M$4.40B$5.14B$9.08BDividend YieldN/A3.63%5.09%4.23%P/E RatioN/A40.5089.7417.16Price / Sales1.843.401,117.09117.04Price / CashN/A7.5543.1037.86Price / Book0.240.844.784.78Net Income-$7.71M$340.44M$120.31M$225.60M7 Day Performance-25.63%-11.61%-1.92%-1.23%1 Month Performance28.51%-8.16%13.65%0.46%1 Year Performance-62.91%-39.14%28.34%15.24% SenesTech Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SNESSenesTech2.5218 of 5 stars$2.93-2.7%$10.00+241.3%-61.4%$3.11M$1.65M0.0030Analyst ForecastNews CoverageGap UpEVGNEvogene2.1583 of 5 stars$1.32-3.6%$12.00+809.1%-84.0%$7.08M$7.48M-0.31140Analyst ForecastPositive NewsGUREGulf ResourcesN/A$0.65+4.8%N/A-55.7%$6.97M$12.80M-0.07380NITON2OFFN/A$0.19-4.4%N/AN/A$2.17M$260,000.000.002Gap UpCNEYCN Energy Group.0.4334 of 5 stars$0.28-11.7%N/A-85.5%$1.96M$66.51M0.0030Positive NewsTANHTantech0.6256 of 5 stars$0.15+2.5%N/A-85.3%$582,000.00$47.32M0.0070Positive NewsGap UpHigh Trading VolumeGAMCWGolden Arrow MergerN/A$0.03flatN/A-83.3%$0.00N/A0.001LNZAWLanzaTech GlobalN/A$0.10+17.6%N/A-82.9%$0.00$58.03M0.003Positive NewsORGNWOrigin MaterialsN/A$0.09-14.2%N/A+80.7%$0.00$35.12M0.00160Positive NewsGap UpPCTTWPureCycle TechnologiesN/A$4.25-0.7%N/A+231.8%$0.00N/A0.00120Positive NewsPCTTUPureCycle TechnologiesN/A$15.72-1.0%N/A+208.2%$0.00N/A0.00120Positive NewsGap Up Related Companies and Tools Related Companies Evogene Competitors Gulf Resources Competitors N2OFF Competitors CN Energy Group. Competitors Tantech Competitors Golden Arrow Merger Competitors LanzaTech Global Competitors Origin Materials Competitors PureCycle Technologies Competitors PureCycle Technologies Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:SNES) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersThis Crypto Is Set to Explode in DecemberIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredAI breakthrough about to upend industryEveryone is talking about AI right now. The talk has been endless ever since ChatGPT was released to the m...Porter & Company | SponsoredNvidia’s Bold Move: Tackling Tech’s $1 Trillion CrisisTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | SponsoredYour bank is lying to you.You might think you have your money in a high-yield savings account, but do you really? The national average A...MyBankTracker | SponsoredMUST SEE: The most important video in the world right now?If you have a significant amount of money in the stock market right now — or if you're sitting on the sideline...InvestorPlace | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minut...Banyan Hill Publishing | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowAltcoin season moves fast, and those who hesitate are left behind. The window is closing.Crypto Swap Profits | SponsoredCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding SenesTech, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share SenesTech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
